Literature DB >> 91612

Some properties of polyethylene glycol:phenylalanine ammonia-lyase adducts.

K J Wieder, N C Palczuk, T van Es, F F Davis.   

Abstract

Methoxypolyethylene glycol of 5000 daltons (PEG) was attached covalently to phenylalanine ammonia-lyase from Rhodotorula glutinis. Attachment of sufficient quantities of PEG to phenylalanine ammonia-lyase substantially reduces immunological recognition and clearance of the conjugated enzyme in mice. The modified enzyme demonstrates altered catalytic properties such as shifts in the pH and temperature optima, an increase in the Michaelis-Menten constant, and a lowered Vmax in comparison with the native enzyme. PEG-phenylalanine ammonia-lyase has increased resistance to proteolytic digestion, particularly when in the presence of cinnamate, a competitive inhibitor, while the native enzyme is rapidly inactivated. In the ultracentrifuge PEG-phenylalanine ammonia-lyase exhibits a lower sedimentation rate than the unmodified enzyme, despite the fact that it is much larger. The electrophoretic mobility of PEG-phenylalanine ammonia-lyase is greatly decreased in comparison to the unmodified enzyme. PEG-phenylalanine ammonia-lyase had a much longer blood-circulating life in mice, both initially and after a number of injections, than did the native enzyme. PEG-phenylalanine ammonia-lyase was a good immunogen but a poor antigen in mice and rabbits, that is, it readily induced antibody formation, but reacted poorly in vitro with the antibodies that were formed against it.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 91612

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  11 in total

Review 1.  Nanomedicine: clinical applications of polyethylene glycol conjugated proteins and drugs.

Authors:  Suphiya Parveen; Sanjeeb K Sahoo
Journal:  Clin Pharmacokinet       Date:  2006       Impact factor: 6.447

2.  Treatment of patients with a history of heparin-induced thrombocytopenia and anti-lepirudin antibodies with argatroban.

Authors:  Job Harenberg; Harenberg Job; Ingrid Jörg; Jörg Ingrid; Tivadar Fenyvesi; Fenyvesi Tivadar; Lukas Piazolo; Piazolo Lukas
Journal:  J Thromb Thrombolysis       Date:  2005-02       Impact factor: 2.300

Review 3.  Pegylated interferons: what role will they play in the treatment of chronic hepatitis C?

Authors:  M L Shiffman
Journal:  Curr Gastroenterol Rep       Date:  2001-02

4.  Phenylalanine ammonia lyase fromSporidiobolus pararoseus andRhodosporidium toruloides: Application for phenylalanine and tyrosine deamination.

Authors:  S Kawasaki Watanabe; G Hernandez-Velazco; F Iturbe-Chiñas; A Lopez-Munguia
Journal:  World J Microbiol Biotechnol       Date:  1992-07       Impact factor: 3.312

Review 5.  Polymer conjugates. Pharmacokinetic considerations for design and development.

Authors:  R Duncan; F Spreafico
Journal:  Clin Pharmacokinet       Date:  1994-10       Impact factor: 6.447

Review 6.  Pharmaceutical and toxicological properties of engineered nanomaterials for drug delivery.

Authors:  Matthew Palombo; Manjeet Deshmukh; Daniel Myers; Jieming Gao; Zoltan Szekely; Patrick J Sinko
Journal:  Annu Rev Pharmacol Toxicol       Date:  2013-10-23       Impact factor: 13.820

7.  CD44v6-Peptide Functionalized Nanoparticles Selectively Bind to Metastatic Cancer Cells.

Authors:  Linxian Li; Mark Schmitt; Alexandra Matzke-Ogi; Parvesh Wadhwani; Veronique Orian-Rousseau; Pavel A Levkin
Journal:  Adv Sci (Weinh)       Date:  2016-12-20       Impact factor: 16.806

8.  Polyethylene glycol modification of a galactosylated streptavidin clearing agent: effects on immunogenicity and clearance of a biotinylated anti-tumour antibody.

Authors:  D Marshall; R B Pedley; J A Boden; R Boden; R G Melton; R H Begent
Journal:  Br J Cancer       Date:  1996-03       Impact factor: 7.640

9.  Formulation and PEGylation optimization of the therapeutic PEGylated phenylalanine ammonia lyase for the treatment of phenylketonuria.

Authors:  Sean M Bell; Dan J Wendt; Yanhong Zhang; Timothy W Taylor; Shinong Long; Laurie Tsuruda; Bin Zhao; Phillip Laipis; Paul A Fitzpatrick
Journal:  PLoS One       Date:  2017-03-10       Impact factor: 3.240

10.  Chemical modification by polyethylene glycol of the anti-tumor enzyme arginine deiminase from Mycoplasma arginini.

Authors:  H Takaku; S Misawa; H Hayashi; K Miyazaki
Journal:  Jpn J Cancer Res       Date:  1993-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.